×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Loan Against Mutual Fund
Apply Now
Gold Loan
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Vouchers
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Eco Pulse
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Global Wealth Summit
Unlocking opportunities in Metal and Mining
Mutual Fund Summit
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
T20 WC 2026
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
PF
Forum
Videos
you are here:
Home
News
Abbreviated New Drug Application
Abbreviated New Drug Application
Jubilant Life gets USFDA nod for arthritis drug
Ajanta Pharma gains 2% on USFDA approval for Duloxetine capsules
Granules India to file 2 ANDAs in US, 4 here this year
Biosimilars to lead growth; generics to be a small part: Biocon
Granules gets US FDA nod for anti-inflammatory drug
Jubilant Life gets USFDA nod for urinary incontinence drug
FDA 483s on Indoco plant not related to data integrity issues
Jubilant Life rises 5% on ANDA approval for hypertension drug
Jubilant Life gains 3% on ANDA approval for Telmisartan tablets
Monsoon, consumption to be big plays for earnings: DSP Blackrock
Natco Pharma rises 7% on USFDA final approval for Tamiflu
Sun Pharma gets FDA nod for rosuvastatin calcium tablets
Natco Pharma gains 9% on USFDA tentative nod for cancer drug
Marksans Pharma surges 13% on USFDA approval for diabetic drug
Unichem Lab gets USFDA nod for schizophrenia tablets
Mayuresh Joshi positive on Sun Pharma
Glenmark sets patent litigation over anti-depressant drug
Aurobindo Pharma gets USFDA nod for oral contraceptives
Unichem Lab gets USFDA nod for hypertension drug
Sun Pharma up 6% on USFDA nod for anti-cancer drug Gleevec
Jubilant Life gets approval for Paroxetine tablets; up 7%
Targeting FY16 margins at 20%: Granules India
Aurobindo gets USFDA nod for generic of Pfizer's Revatio
Jubilant Life gets USFDA nod for generic dementia tablets
Unichem gets USFDA nod to market Alzheimer treatment drug
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio